Atrial Fibrillation Market to Rise at Over 6% CAGR from 2022 to 2031, Reaching a Valuation of US$ 18.5 billion: TMR Report

The global 𝐚𝐭𝐫𝐢𝐚𝐥 𝐟𝐢𝐛𝐫𝐢𝐥𝐥𝐚𝐭𝐢𝐨𝐧 𝐦𝐚𝐫𝐤𝐞𝐭, valued at US$ 10.2 billion in 2021, is poised for substantial growth, with a projected CAGR of 6% from 2022 to 2031, reaching an estimated value surpassing US$ 18.5 billion by 2031.

Hypertension and obesity stand as primary contributors to cardiovascular disorders, notably atrial fibrillation, with their prevalence escalating due to lifestyle-induced factors like diet, alcohol intake, and smoking. The expanding elderly population further fuels this growth, given their heightened susceptibility to atrial fibrillation. Clinical trials demonstrating the efficacy of combined pharmacological therapies address unmet medical needs in this domain, propelling market expansion. Companies are increasingly investing in such trials to enhance treatment options. Additionally, the introduction of advanced procedures like hybrid ablation and the escalating incidence of atrial fibrillation in emerging Asian economies are expected to drive market momentum forward.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1541&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

AtriCure, Inc., Biosense Webster, Inc., Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Corporation, CardioFocus, Inc., Endoscopic Technologies, Inc., Sanofi Aventis, St. Jude Medical, Inc., and Johnson & Johnson Ltd, among others.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

Treatment Type

Pharmacological Treatment
Anti-arrhythmic Drugs
Anti-coagulant Drugs
Non-pharmacological Treatment
Catheter Ablation
Radiofrequency Based
Cryoablation Based
HIFU (High Intensity Focused Ultrasound) Based
Microwave Based
Laser Based
Maze Surgery
Electric Cardioversion

𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬:

In January 2022, Voluntis, an Aptar Pharma company and leader in digital therapeutics has entered into a partnership agreement with AliveCor, Inc. for Advance Management of Atrial Fibrillation for Patients with Cancer

In July 2021, AliveCor, Inc. and Acutus Medical have announced a partnership to evaluate the integration of data collection tools across the cardiology continuum of care, with the goal of improving arrhythmia treatment and disease management

In May 2020, CardioFocus, Inc. announced that it has received the U.S. Food & Drug administration approval for its next-generation HearLight X3 Endoscopic Ablation System. The system can be used for the drug refractory recurrent symptomatic paroxysmal atrial fibrillation treatment.

In September 2019, iRhythm Technologies, Inc. announced a collaboration with Verily, an Alphabet company, to develop solutions to improve the screening, diagnosis, and management of atrial fibrillation patients (AFib)

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

In terms of region, the global atrial fibrillation market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global atrial fibrillation market in 2021, followed by Europe.

North America is a leading market for atrial fibrillation due to high prevalence of atrial fibrillation, high disposable income of patients, and sophisticated healthcare infrastructure. Emerging markets in Asia Pacific exhibit immense growth potential due to initiatives taken by governments to promote healthcare and robust economic growth. Moreover, improving purchasing power, consumer awareness about health issues, and better disease management are likely to fuel the growth of the atrial fibrillation market in Asia Pacific.

𝐆𝐞𝐭 𝐓𝐡𝐢𝐬 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭, 𝐈𝐧𝐬𝐭𝐚𝐧𝐭𝐥𝐲:
https://www.transparencymarketresearch.com/checkout.php?rep_id=1541<ype=S&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

Key trends shaping the atrial fibrillation market include the adoption of telemedicine and digital health solutions for remote patient monitoring, the emergence of personalized medicine approaches, and the integration of artificial intelligence in healthcare delivery for more precise diagnosis and treatment planning.

𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

The future outlook for the atrial fibrillation market appears promising, with sustained investments in research and development, technological innovations, and strategic collaborations among industry players. Additionally, the increasing focus on preventive healthcare measures and patient-centric approaches is expected to drive market growth further.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲 𝐏𝐨𝐢𝐧𝐭𝐬:

Incidence and prevalence rates of atrial fibrillation
Emerging treatment modalities and their efficacy
Healthcare expenditure trends in key regions
Regulatory landscape and approval processes for new therapies

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐌𝐑:

𝐁𝐚𝐭𝐭𝐞𝐫𝐲 𝐏𝐚𝐜𝐤 𝐌𝐨𝐝𝐮𝐥𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/05/19/2672448/0/en/Battery-Pack-Modules-Market-for-EVs-Size-is-Expected-to-Reach-US-85-8-Bn-by-2031-Rising-at-a-Market-Growth-of-15-7-CAGR-During-the-Forecast-Period-Transparency-Market-Research-Inc.html

𝐌𝐨𝐭𝐨𝐫𝐜𝐲𝐜𝐥𝐞 𝐓𝐢𝐫𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/05/19/2672415/0/en/Motorcycle-Tires-Market-to-Grow-at-a-CAGR-of-7-2-during-the-2023-to-2031-Forecast-Period-TMR-Study.html

𝐀𝐛𝐨𝐮𝐭 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com    
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.